Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Forward Ventures is a life-science venture capital firm founded in 1990 and based in San Diego, California. The firm manages over $450 million in assets under management (AUM) and has invested in more than 60 companies across five funds. Forward Ventures primarily focuses on biopharmaceutical therapeutics, aiming to provide significant financial returns to its limited partners by investing in companies that develop innovative therapies for unmet medical needs.
The firm has a long history of successful investments, with notable exits including Dynavax, Syndax Pharmaceuticals, and Acorda Therapeutics. Forward Ventures has established itself as a key player in the life sciences sector, leveraging its extensive experience to guide portfolio companies through various stages of development. The firm is committed to addressing critical healthcare challenges and supporting the commercialization of groundbreaking therapies.
Forward Ventures invests in life sciences and biopharmaceuticals at all stages of company development, from Friends & Family to Growth Equity. The firm emphasizes companies with strong underlying technology, data, and intellectual property, as well as a capable management team. Their investment strategy includes a focus on addressing unmet medical needs and large commercial markets, with a clear regulatory pathway for the products.
Investment checks typically range across various stages, allowing for flexibility in funding. Forward Ventures seeks to partner with companies that demonstrate potential for significant impact in the healthcare sector. The firm’s thesis revolves around identifying innovative therapies that can address pressing medical challenges, ensuring that their investments are well-positioned for success in the market.
Forward Ventures has a diverse portfolio of over 60 companies, with notable investments including:
These companies exemplify Forward Ventures' commitment to investing in innovative solutions within the biopharmaceutical sector.
Standish M. Fleming: Co-Founder & Managing Member. Standish has over 30 years of experience in venture capital and has served on the boards of 19 portfolio companies. He has a strong background in life sciences and has been instrumental in guiding investments in the sector.
To pitch Forward Ventures, founders should send an email to info@forwardventures.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. The firm does not currently accept unsolicited business plans, so a direct email is the preferred method of contact. Response times may vary, but founders should expect a thorough review of their submission.
In December 2025, Forward Ventures celebrated the acquisition of Dynavax by Sanofi for approximately $2.2 billion, marking a significant exit for the firm. This acquisition highlights the firm's successful track record in the life sciences sector.
As of 2026, there have been no new investment announcements from Forward Ventures, suggesting that the firm may be in a harvest mode following its recent successes. The firm has not publicly referenced a new fund since Fund V, indicating a potential pause in active deployment.
What are Forward Ventures' investment criteria?
Forward Ventures focuses on life sciences and biopharmaceuticals, targeting companies with strong underlying technology, data, and intellectual property. They look for businesses that address unmet medical needs and have a clear regulatory pathway for their products.
How can I pitch to Forward Ventures?
Founders can reach out via email at info@forwardventures.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team qualifications.
What stages does Forward Ventures invest in?
The firm invests across all stages, including Friends & Family, Angel, Pre-seed, Seed, Seed+, Series A, Series B, Series C, and Growth Equity. This allows them to support companies at various points in their development.
What makes Forward Ventures different from other VCs?
Forward Ventures has a strong focus on the life sciences sector, with a proven track record of successful exits and a deep understanding of the biopharmaceutical landscape. Their extensive experience allows them to provide valuable strategic guidance to portfolio companies.
What is the geographic focus of Forward Ventures?
The firm primarily invests in North America, concentrating on companies that are developing innovative therapies within the biotech and healthcare sectors.
What kind of post-investment support does Forward Ventures provide?
Forward Ventures adds value to its portfolio companies by leveraging its extensive experience in the life sciences sector, providing strategic guidance, and facilitating connections within the industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.